Altoida Raises $6.3M for Early Detection of Alzheimer's Using AI & Augmented Reality -

Altoida Inc., a digital health company using digital biomarkers to drive better clinical outcomes for brain diseases has raised $6.3M in Series A funding led by M Ventures, the corporate venture capital arm of the science and technology company Merck KGaA, Darmstadt, Germany. The round also includes participation from Grey Sky Venture Partners, VI Partners AG, Alpana Ventures, and FYRFLY Venture Partners. The number of people living with Alzheimer's disease is rapidly growing. In 2019 alone, Alzheimer's disease and other dementias will cost the nation $290 billion. By 2050, these costs could rise as high as $1.1 trillion.